1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CATALYST BIOSCIENCES INC

Catalyst Biosciences Inc

XNAS: CBIO

Watchlist

Portfolio

Share


Insider Trading disclosures for Catalyst Biosciences Inc

The latest disclosure was made by Nassim Usman in Catalyst Biosciences Inc where a trade of 3,250 Common Stock done at an average price of $0.5 was reported to US exchanges on Aug. 9, 2022.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.47 per share. 09 Aug 2022 3,250 24,541 (0%) 0% 0.5 1,528 Common Stock
Grant E. Blouse Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.47 per share. 09 Aug 2022 3,250 9,417 (0%) 0% 0.5 1,528 Common Stock
Seline Miller SVP Finance; Interim CFO & PAO Purchase of securities on an exchange or from another person at price $ 0.47 per share. 09 Aug 2022 3,250 6,500 (0%) 0% 0.5 1,528 Common Stock
Grant E. Blouse Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 200,000 200,000 - - Stock Option (Right to Buy)
Seline Miller SVP Finance; Interim CFO & PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 107,500 107,500 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.46 per share. 09 Feb 2022 3,250 21,291 (0%) 0% 0.5 1,495 Common Stock
Grant E. Blouse Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.46 per share. 09 Feb 2022 3,250 6,167 (0%) 0% 0.5 1,495 Common Stock
Seline Miller SVP Finance; Interim CFO & PAO Purchase of securities on an exchange or from another person at price $ 0.46 per share. 09 Feb 2022 3,250 3,250 (0%) 0% 0.5 1,495 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 7,521 28,228 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 12,308 34,804 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 12,855 31,790 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 5,839 24,573 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 3,588 29,801 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 1,824 20,707 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 2,980 22,496 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 2,858 18,935 (0%) 0% 0 Common Stock
Jeanne Y. Jew Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2021 28,000 28,000 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 3.62 per share. 09 Aug 2021 867 18,041 (0%) 0% 3.6 3,139 Common Stock
Howard Levy Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.62 per share. 09 Aug 2021 639 639 (0%) 0% 3.6 2,313 Common Stock
Grant E. Blouse Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 3.62 per share. 09 Aug 2021 1,163 2,917 (0%) 0% 3.6 4,210 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 5,542 18,734 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 3,406 26,213 (0%) 0% 0 Common Stock
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 2,886 18,883 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 1,414 19,516 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 2,713 16,077 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 14,000 14,000 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 05 Apr 2021 5,000 17,174 (0%) 0% 4.6 23,150 Common Stock
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2021 5,000 259,783 - - Stock Option (Right to Buy)
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 4,761 13,192 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 2,926 22,807 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 2,480 15,997 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 1,215 18,102 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2021 2,331 13,364 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 4.81 per share. 09 Feb 2021 582 12,174 (0%) 0% 4.8 2,799 Common Stock
Howard Levy Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.81 per share. 09 Feb 2021 1,670 23,390 (0%) 0% 4.8 8,033 Common Stock
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2021 140,000 140,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2021 25,000 25,000 - - Stock Option (Right to Buy)
Clinton Musil Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2021 54,000 54,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 3,417 8,431 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 2,129 19,881 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 1,881 13,517 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 940 16,887 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 1,782 11,033 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 5,014 5,014 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 3,125 17,752 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 2,761 11,636 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 1,380 15,947 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 2,616 9,251 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 4.81 per share. 10 Aug 2020 582 11,592 (0%) 0% 4.8 2,799 Common Stock
Howard Levy Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.81 per share. 10 Aug 2020 1,768 4,268 (0%) 0% 4.8 8,504 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 3,673 24,215 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 2,129 14,627 (0%) 0% 0 Common Stock
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 1,703 3,635 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 2,076 8,875 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 1,011 14,567 (0%) 0% 0 Common Stock
Clinton Musil Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 140,000 140,000 - - Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 1,703 6,635 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 5,000 5,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 4,934 20,542 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 2,860 12,498 (0%) 0% 0 Common Stock
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 1,932 1,932 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 1,673 6,799 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 2,717 13,556 (0%) 0% 0 Common Stock
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 1,932 4,932 (0%) 0% 0 Common Stock
Howard Levy Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.05 per share. 16 Mar 2020 2,500 2,500 (0%) 0% 4.1 10,132 Common Stock
John P. Richard Director Purchase of securities on an exchange or from another person at price $ 3.98 per share. 13 Mar 2020 2,500 3,716 (0%) 0% 4.0 9,950 Common Stock
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 3.91 per share. 13 Mar 2020 4,000 11,010 (0%) 0% 3.9 15,647 Common Stock
Veronica Cai Controller Purchase of securities on an exchange or from another person at price $ 4.11 per share. 13 Mar 2020 2,000 7,353 (0%) 0% 4.1 8,220 Common Stock
Edward Williams Director Purchase of securities on an exchange or from another person at price $ 5.78 per share. 04 Mar 2020 2,000 10,839 (0%) 0% 5.8 11,560 Common Stock
Augustine J. Lawlor Director Sale of securities on an exchange or to another person at price $ 6.10 per share. 25 Feb 2020 69,401 0 (0%) 0% 6.1 423,506 Common Stock
Geoffrey Shiu Fei Ling Director Purchase of securities on an exchange or from another person at price $ 6.23 per share. 25 Feb 2020 3,000 3,000 (0%) 0% 6.2 18,692 Common Stock
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 6.23 per share. 10 Feb 2020 430 7,010 (0%) 0% 6.2 2,679 Common Stock
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 6.23 per share. 10 Feb 2020 1,358 1,358 (0%) 0% 6.2 8,460 Common Stock
Veronica Cai Controller Grant, award, or other acquisition of securities at price $ 6.23 per share. 10 Feb 2020 1,678 5,353 (0%) 0% 6.2 10,454 Common Stock
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2020 115,000 115,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2020 45,000 45,000 - - Stock Option (Right to Buy)
Veronica Cai Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2020 12,000 12,000 - - Stock Option (Right to Buy)
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2020 10,000 10,000 - - Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2020 10,000 10,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 3,166 15,608 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 1,835 9,638 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 1,073 5,126 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 1,743 8,839 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2019 4,391 12,442 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2019 2,545 7,803 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2019 1,489 4,053 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2019 2,418 7,096 (0%) 0% 0 Common Stock
Veronica Cai Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2019 3,000 3,000 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 6.51 per share. 12 Aug 2019 413 6,580 (0%) 0% 6.5 2,689 Common Stock
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 6.51 per share. 12 Aug 2019 1,180 3,744 (0%) 0% 6.5 7,682 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2019 2,905 8,051 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2019 1,810 5,258 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2019 1,036 2,564 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2019 1,642 4,678 (0%) 0% 0 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,000 5,000 - - Stock Option (Right to Buy)
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,000 5,000 - - Stock Option (Right to Buy)
John P. Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,000 5,000 - - Stock Option (Right to Buy)
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,000 5,000 - - Stock Option (Right to Buy)
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,000 5,000 - - Stock Option (Right to Buy)
John P. Richard Director Purchase of securities on an exchange or from another person at price $ 8.03 per share. 24 May 2019 1,000 1,216 (0%) 0% 8.0 8,030 Common Stock
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 21 May 2019 4,400 10,567 (0%) 0% 4.6 20,372 Common Stock
Nassim Usman Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 21 May 2019 4,400 6,167 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 21 May 2019 4,400 8,456 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 4,400 264,783 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 4,400 81,218 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Gift of securities by or to the insider at price $ 0.00 per share. 21 May 2019 16,094 16,094 (0%) 0% 0 Common Stock
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 21 May 2019 4,400 16,094 (0%) 0% 4.6 20,372 Common Stock
Augustine J. Lawlor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 2,414 5,146 (0%) 0% 0 Common Stock
Desouza B Errol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 1,504 3,448 (0%) 0% 0 Common Stock
Andrea S. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 717 1,528 (0%) 0% 0 Common Stock
Edward Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 1,364 3,036 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 7.04 per share. 11 Feb 2019 350 6,167 (0%) 0% 7.0 2,464 Common Stock
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 7.04 per share. 11 Feb 2019 1,002 3,731 (0%) 0% 7.0 7,054 Common Stock
Fletcher Payne Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 04 Feb 2019 1,503 3,230 (0%) 0% 4.6 6,959 Common Stock
Fletcher Payne Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Feb 2019 1,503 73,497 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 31 Jan 2019 5,729 11,041 (0%) 0% 4.6 26,525 Common Stock
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 5,729 269,271 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 1,500 93,500 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 31 Jan 2019 1,500 9,382 (0%) 0% 4.6 6,945 Common Stock
Nassim Usman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 80,000 80,000 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 38,000 38,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 35,000 35,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2018 2,732 2,732 (0%) 0% 0 Common Stock
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2018 1,703 1,944 (0%) 0% 0 Common Stock
Andrea S. Hunt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2018 811 811 (0%) 0% 0 Common Stock
Edward Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2018 1,544 1,672 (0%) 0% 0 Common Stock
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 26 Nov 2018 149 7,709 (0%) 0% 4.6 690 Common Stock
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2018 149 87,118 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2018 173 87,267 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.00 per share. 16 Nov 2018 173 7,560 (0%) 0% 11 1,903 Common Stock
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 16 Nov 2018 173 7,733 (0%) 0% 4.6 801 Common Stock
Stephen A. Hill None Sale or transfer of securities back to the company at price $ 10.07 per share. 06 Sep 2018 190 1,190 (0%) 0% 10.1 1,913 Common Stock
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2018 75,000 75,000 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2018 25,000 25,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2018 35,000 35,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
Stephen A. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
Andrea S. Hunt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
Edward Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 5,000 5,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 03 May 2018 7,560 7,560 (0%) 0% 4.6 35,003 Common Stock
Howard Levy Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 May 2018 7,560 87,440 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 09 Apr 2018 88 0 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 09 Apr 2018 88 4,144 (0%) 0% 0 Common Stock
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2018 88 274,912 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.62 per share. 04 Apr 2018 88 88 (0%) 0% 4.6 407 Common Stock
Fletcher Payne Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2018 59 74,941 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 26 Mar 2018 59 59 (0%) 0% 4.6 273 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 29.94 per share. 06 Mar 2018 3,617 322,076 (2%) 0% 29.9 108,293 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 29.03 per share. 06 Mar 2018 2,233 305,965 (2%) 0% 29.0 64,824 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 29.03 per share. 06 Mar 2018 5,890 807,257 (7%) 0% 29.0 170,987 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 30.00 per share. 06 Mar 2018 328 308,198 (2%) 0% 30 9,840 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 30.00 per share. 06 Mar 2018 866 813,147 (7%) 0% 30 25,980 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 30.00 per share. 06 Mar 2018 2,748 308,526 (2%) 0% 30 82,440 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 30.00 per share. 06 Mar 2018 7,252 814,013 (7%) 0% 30 217,560 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 31.18 per share. 06 Mar 2018 10,802 311,274 (2%) 0% 31.2 336,806 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 31.18 per share. 06 Mar 2018 28,498 821,265 (7%) 0% 31.2 888,568 Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 29.94 per share. 06 Mar 2018 9,544 849,763 (7%) 0% 29.9 285,747 Common Stock
Desouza B Errol None Other type of transaction at price $ 0.00 per share. 20 Feb 2018 4,679 0 - - Redeemable Convertible Note
Stephen A. Hill None Other type of transaction at price $ 0.00 per share. 20 Feb 2018 21,600 0 - - Redeemable Convertible Note
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2018 10,000 10,000 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2018 500 500 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2018 550 550 - - Stock Option (Right to Buy)
Harold E. Selick None Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Jan 2018 550 0 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2018 197 197 - - Stock Option (Right to Buy)
Harold E. Selick None Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Jan 2018 197 0 - - Stock Option (Right to Buy)
Harold E. Selick None Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Jan 2018 10,000 0 - - Stock Option (Right to Buy)
Harold E. Selick None Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Jan 2018 500 0 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2018 450 450 - - Stock Option (Right to Buy)
Harold E. Selick None Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Jan 2018 450 0 - - Stock Option (Right to Buy)
Nassim Usman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2018 95,000 95,000 - - Stock Option(Right to Buy)
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2018 26,000 26,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2018 33,000 33,000 - - Stock Option(Right to Buy)
Edward Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2018 10,000 10,000 - - Stock Option (Right to Buy)
Andrea S. Hunt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2017 10,000 10,000 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 10,000 10,000 - - Stock Option (Right to Buy)
Stephen A. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 10,000 10,000 - - Stock Option (Right to Buy)
Augustine J. Lawlor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 10,000 10,000 - - Stock Option (Right to Buy)
John P Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 10,000 10,000 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2017 10,000 10,000 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2017 275,000 275,000 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2017 75,000 75,000 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2017 95,000 95,000 - - Stock Option (Right to Buy)
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2016 7,500 7,500 - - Stock Option (Right to Buy)
Stephen A. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2016 7,500 7,500 - - Stock Option (Right to Buy)
Augustine J. Lawlor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2016 7,500 7,500 - - Stock Option (Right to Buy)
John P Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2016 7,500 7,500 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2016 7,500 7,500 - - Stock Option (Right to Buy)
Howard Levy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2016 100,000 100,000 - - Stock Option (Right to Buy)
Stephen A. Hill None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Dec 2015 5,000 20,711 - - Common Stock
Nassim Usman Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Dec 2015 4,000 78,375 - - Common Stock
Fletcher Payne Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Dec 2015 10,000 25,032 - - Common Stock
Harold E. Selick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 6,750 6,750 - - Stock Option (Right to Buy)
Stephen A. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 6,750 6,750 - - Stock Option (Right to Buy)
Augustine J. Lawlor None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 6,750 6,750 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 6,750 6,750 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 6,750 6,750 - - Stock Option (Right to Buy)
Nassim Usman Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 153,572 153,572 - - Stock Option (Right to Buy)
Edwin L. Madison Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 58,572 58,572 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2015 28,572 28,572 - - Stock Option (Right to Buy)
Stephen A. Hill None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 Aug 2015 12,146 15,711 - - Common Stock
Harold E. Selick None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 287 287 - - Warrant (Right to Buy)
Harold E. Selick None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 16,232 16,232 - - Common Stock
Harold E. Selick None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 2,966 2,966 - - Stock Option (Right to Buy)
Harold E. Selick None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 382 16,614 - - Common Stock
Augustine J. Lawlor None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 1,041,024 1,041,024 - - Common Stock
Augustine J. Lawlor None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 2,254 2,254 - - Warrant (Right to Buy)
Augustine J. Lawlor None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 14,056 14,056 - - Warrant (Right to Buy)
Augustine J. Lawlor None Other type of transaction at price $ 0.00 per share. 20 Aug 2015 11,383 11,383 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 220 220 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 556 556 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 1,068,790 1,068,790 - - Common Stock
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 96 96 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 21,926 21,926 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 77,059 1,145,849 - - Common Stock
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 3,065 3,065 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 1,280 1,280 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 687 687 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 17,757 17,757 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 1,580 1,580 - - Warrant (Right to Buy)
Jeff W. Himawan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Aug 2015 33,503 1,179,352 - - Common Stock
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 29 29 - - Warrant (Right to Buy)
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 8,786 8,786 - - Stock Option (Right to Buy)
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 60,847 60,847 - - Common Stock
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 22,508 22,508 - - Stock Option (Right to Buy)
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 61,118 61,118 - - Stock Option (Right to Buy)
Nassim Usman Director, President and CEO Other type of transaction at price $ 0.00 per share. 20 Aug 2015 13,528 74,375 - - Common Stock
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 11,254 11,254 - - Stock Option (Right to Buy)
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 3,820 3,820 - - Stock Option (Right to Buy)
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 29 29 - - Warrant (Right to Buy)
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 6,501 6,501 - - Stock Option (Right to Buy)
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 26,809 26,809 - - Stock Option (Right to Buy)
Edwin L. Madison Chief Scientific Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 31,008 31,008 - - Common Stock
Fletcher Payne Chief Financial Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 15,032 15,032 - - Common Stock
Fletcher Payne Chief Financial Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 7,320 7,320 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 14,325 14,325 - - Stock Option (Right to Buy)
Fletcher Payne Chief Financial Officer Other type of transaction at price $ 0.00 per share. 20 Aug 2015 2,440 2,440 - - Stock Option (Right to Buy)
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2015 12,500 12,500 - - Stock Option (Right to Buy)
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2015 12,500 12,500 - - Stock Option (Right to Buy)
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2015 12,500 12,500 - - Stock Option (Right to Buy)
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2014 10,000 10,000 - - Common Stock
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2014 10,000 10,000 - - Common Stock
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2014 10,000 10,000 - - Common Stock
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2014 10,000 15,333 - - Common Stock
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2014 10,000 15,333 - - Common Stock
Stephen A. Hill Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2014 175,000 195,000 - - Common Stock
Alan A. Musso SVP, Fin+Admin, CFO & Treas Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2014 55,000 57,799 - - Common Stock
Steven M. Toler VP, Clin Pharm Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2014 45,000 46,000 - - Common Stock
Patrick C. Rock SVP, GC and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2014 45,000 45,000 - - Common Stock
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2014 12,500 12,500 - - Stock Option (Right to Buy)
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2014 12,500 12,500 - - Stock Option (Right to Buy)
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2014 12,500 12,500 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2014 17,500 17,500 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2014 12,500 12,500 - - Stock Option (Right to Buy)
Stephen A. Hill Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2014 175,000 175,000 - - Stock Option (Right to Buy)
Alan A. Musso SVP, Fin+Admin, CFO & Treas Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2014 55,000 55,000 - - Stock Option (Right to Buy)
Steven M. Toler VP, Clin Pharm Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2014 45,000 45,000 - - Stock Option (Right to Buy)
David A. Hosford VP, Clin Dev & Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2014 45,000 45,000 - - Stock Option (Right to Buy)
Patrick C. Rock SVP, GC and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2014 45,000 45,000 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2014 10,000 10,000 - - Common Stock, $0.001 par value per share
Peter J. Barris Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2013 1,000 0 - - Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2013 1,000 0 - - Common Stock
M. James Barrett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Dec 2013 15,000 0 - - Common Stock
M. James Barrett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Dec 2013 1,000 0 - - Common Stock
M. James Barrett Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Dec 2013 7,500 7,500 - - Common Stock
M. James Barrett Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Dec 2013 7,500 15,000 - - Common Stock
M. James Barrett Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Dec 2013 7,500 0 - - Director Stock Option (right to buy)
M. James Barrett Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Dec 2013 7,500 0 - - Director Stock Option (right to buy)
M. James Barrett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2013 5,333 1,000 - - Common Stock
Peter J. Barris Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2013 5,333 1,000 - - Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2013 5,333 1,000 - - Common Stock
Patrick C. Rock SVP, GC and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2013 100,000 100,000 - - Common Stock, $0.001 par value per share
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 12,500 12,500 - - Stock Option (Right to Buy)
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 12,500 12,500 - - Stock Option (Right to Buy)
Mark B. Skaletsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 17,500 17,500 - - Stock Option (Right to Buy)
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 12,500 12,500 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 12,500 12,500 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2013 12,500 12,500 - - Stock Option (Right to Buy)
M. James Barrett Ten Percent Owner 03 Jun 2013 1,000 6,333 - - Common Stock
M. James Barrett Ten Percent Owner 03 Jun 2013 1,000 0 - - Stock Option (Right to Buy)
Peter J. Barris Ten Percent Owner 03 Jun 2013 1,000 6,333 - - Common Stock
Peter J. Barris Ten Percent Owner 03 Jun 2013 1,000 0 - - Stock Option (Right to Buy)
Sandell D Scott Ten Percent Owner 03 Jun 2013 1,000 6,333 - - Common Stock
Sandell D Scott Ten Percent Owner 03 Jun 2013 1,000 0 - - Stock Option (Right to Buy)
Julia R. Brown None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 May 2013 6,000 6,000 - - Common Stock
Stephen A. Hill Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Mar 2013 10,000 20,000 - - Common Stock
Stephen A. Hill Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Mar 2013 10,000 10,000 - - Common Stock
Merouane Bencherif SVP and Senior Scien Fellow Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 40,000 40,000 - - Stock Option (Right to Buy)
Jefferey P. Brennan SVP, Bus. and Comm. Dev. & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 65,000 65,000 - - Stock Option (Right to Buy)
Alan A. Musso SVP, Fin+Admin, CFO & Treas Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 65,000 65,000 - - Stock Option (Right to Buy)
Peter A. Zorn SVP, Lgl Affrs, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 65,000 65,000 - - Stock Option (Right to Buy)
Karen A. Hicks VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 40,000 40,000 - - Stock Option (Right to Buy)
Mauri K. Hodges VP, Fin+Corp Sys & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 40,000 40,000 - - Stock Option (Right to Buy)
Steven M. Toler VP, Clin Pharm Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 45,000 45,000 - - Stock Option (Right to Buy)
David A. Hosford VP, Clin Dev & Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2013 45,000 45,000 - - Stock Option (RIght to Buy)
Stephen A. Hill Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2012 400,000 400,000 - - Stock Option (Right to Buy)
C. Richard Kramlich Ten Percent Owner 19 Nov 2012 3,333 0 - - Stock Option (Right to Buy)
C. Richard Kramlich Ten Percent Owner 19 Nov 2012 3,333 5,333 - - Common Stock
Peter J. Barris Ten Percent Owner 19 Nov 2012 3,333 0 - - Stock Option (Right to Buy)
Peter J. Barris Ten Percent Owner 19 Nov 2012 3,333 5,333 - - Common Stock
Sandell D Scott Ten Percent Owner 19 Nov 2012 3,333 0 - - Stock Option (Right to Buy)
Sandell D Scott Ten Percent Owner 19 Nov 2012 3,333 5,333 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Nov 2012 378,000 2,977,919 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Nov 2012 217,000 1,713,907 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2012 31,929 1,827,856 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2012 17,400 1,052,258 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2012 8,800 1,034,858 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2012 14,300 1,795,927 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 21,500 1,026,058 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 46,700 1,738,827 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 36,100 1,781,627 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 23,400 1,004,558 - - CommonStock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 5,300 981,158 - - Common Stock
Mark N. Lampert Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2012 6,700 1,745,527 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2012 4,333 4,333 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2012 4,333 0 - - Stock Option (Right to Buy)
Mark B. Skaletsky Director, Member, Office of the Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2012 57,500 57,500 - - Stock Option (Right to Buy)
John P. Richard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Jun 2012 7,500 7,500 - - Common Stock
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
G. Steven Burrill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
M. James Barrett Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Director Stock Option (Right to Buy)
Ralph Snyderman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2012 7,500 7,500 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2012 15,938 15,938 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2012 15,938 7,970 - - Stock Option (Right to Buy)
J. Donald deBethizy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 135,000 135,000 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 90,000 90,000 - - Stock Option (Right to Buy)
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 100,000 100,000 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 100,000 100,000 - - Stock Option (Right to Buy)
Peter A. Zorn SVP, Lgl Affrs, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 100,000 100,000 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 60,000 60,000 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin+Corp Sys and Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2012 60,000 60,000 - - Stock Option (Right to Buy)
J. Donald deBethizy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2012 798 798 - - Common Stock
J. Donald deBethizy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2012 798 0 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Gift of securities by or to the insider at price $ 0.00 per share. 20 Sep 2011 500 7,235 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Gift of securities by or to the insider at price $ 0.00 per share. 20 Sep 2011 500 6,735 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Gift of securities by or to the insider at price $ 0.00 per share. 20 Sep 2011 500 500 - - Common Stock
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2011 2,500 2,500 - - Stock Option (Right to Buy)
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2011 2,500 7,833 - - Common Stock
John P. Richard None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2011 2,500 5,333 - - Common Stock
Julia R. Brown None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
G. Steven Burrill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
Alan W. Dunton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
Mark B. Skaletsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 12,500 12,500 - - Stock Option (Right to Buy)
M. James Barrett Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Director Stock Option (Right to Buy)
Ralph Snyderman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
Charles A. Blixt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
Desouza B Errol None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2011 7,500 7,500 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 11,627 0 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 2,880 0 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 16,368 49,107 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 11,627 14,426 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 2,880 17,306 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2011 16,368 33,674 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jun 2011 30,875 2,799 - - Common Stock
Julia R. Brown None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2011 9,100 9,100 - - Common Stock
Julia R. Brown None Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 May 2011 9,100 0 - - Common Stock
Julia R. Brown None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2011 9,100 3,400 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 16,948 16,948 - - Common Stock
G. Steven Burrill None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 May 2011 16,948 0 - - Common Stock
G. Steven Burrill None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 May 2011 2,000 0 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 10,552 10,552 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 18,052 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 25,552 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 33,052 - - Common Stock
G. Steven Burrill None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 May 2011 33,052 0 - - Common Stock
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 16,948 3,052 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 3,052 0 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 0 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 0 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 0 - - Stock Option (Right to Buy)
G. Steven Burrill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2011 7,500 0 - - Stock Option (Right to Buy)
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2011 2,500 7,833 - - Common Stock
John P. Richard None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2011 2,500 5,333 - - Common Stock
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2011 2,500 5,000 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2011 2,655 18,595 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2011 2,655 10,390 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Mar 2011 2,655 7,735 - - Common Stock
J. Donald deBethizy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 105,000 105,000 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 40,000 40,000 - - Stock Option (Right to Buy)
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 50,000 50,000 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 40,000 40,000 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 55,500 55,500 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 50,000 50,000 - - Stock Option (Right to Buy)
Peter A. Zorn SVP, Lgl Affrs, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 50,000 50,000 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 30,500 30,500 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin+Corp Sys and Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2011 30,500 30,500 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2011 1,500 2,659 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Mar 2011 1,500 1,159 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2011 1,500 6,198 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2011 5,030 8,198 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2011 500 7,698 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2011 5,030 6,189 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Mar 2011 5,030 1,159 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2011 500 1,659 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Mar 2011 500 1,159 - - Common Stock
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 1,264 1,264 - - Common Stock
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2011 1,264 0 - - Common Stock
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 1,264 31,394 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 468 468 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 775 1,243 - - Common Stock
Karen A. Hicks VP Human Resources Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2011 1,243 0 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 468 32 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 775 2,325 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 200 1,359 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2011 200 1,159 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 12,703 13,428 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 200 13,228 - - Stock Option (Right to Buy)
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2011 12,703 13,862 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2011 12,703 1,159 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2011 15,481 0 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2011 11,360 31,472 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2011 15,481 23,216 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2011 15,481 7,735 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2011 11,360 19,095 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2011 11,360 7,735 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2011 16,655 21,250 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2011 16,655 24,390 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 16,655 7,735 - - Common Stock
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 2,500 7,833 - - Common Stock
John P. Richard None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jan 2011 2,500 5,333 - - Common Stock
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 5,000 10,333 - - Common Stock
John P. Richard None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jan 2011 5,000 5,333 - - Common Stock
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 2,500 5,000 - - Stock Option (Right to Buy)
John P. Richard None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 5,000 0 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 22,800 7,951 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 7,951 0 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 22,252 0 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jan 2011 30,203 0 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 22,800 22,800 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jan 2011 22,800 0 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 7,951 7,951 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jan 2011 22,252 30,203 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2011 3,369 3,369 - - Common Stock
Karen A. Hicks VP Human Resources Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jan 2011 3,369 0 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2011 1,719 1,719 - - Common Stock
Karen A. Hicks VP Human Resources Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jan 2011 1,719 0 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2011 3,369 15,469 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2011 1,719 13,750 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 6,006 6,006 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 10,531 0 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 3,294 9,106 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 6,006 3,100 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 5,225 18,838 - - Stock Option (Right to Buy)
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 5,225 11,231 - - Common Stock
Karen A. Hicks VP Human Resources Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jan 2011 11,231 0 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 10,531 10,531 - - Common Stock
Karen A. Hicks VP Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2011 3,294 13,825 - - Common Stock
Karen A. Hicks VP Human Resources Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jan 2011 13,825 0 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2010 15,535 18,334 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Dec 2010 15,535 2,799 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2010 4,881 7,680 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Dec 2010 4,881 2,799 - - Common Stock
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2010 8,789 0 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2010 6,746 16,508 - - Stock Option (Right to Buy)
Alan A. Musso SVP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2010 4,881 11,627 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2010 2,100 0 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2010 6,782 0 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2010 2,100 2,100 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2010 2,100 3,253 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Dec 2010 2,100 1,153 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2010 8,882 10,035 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Dec 2010 8,882 1,153 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2010 200 4,200 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2010 200 1,353 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Dec 2010 200 1,153 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2010 2,700 3,859 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Dec 2010 2,700 1,159 - - Common Stock
Mauri K. Hodges VP Fin + Corp Sys & Controller Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2010 2,700 18,390 - - Stock Option (Right to Buy)
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2010 10,000 10,000 - - Common Stock
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Dec 2010 10,000 0 - - Common Stock
Jefferey P. Brennan SVP - Bus. & Commercial Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2010 10,000 32,658 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2010 12,000 0 - - Stock Option (Right to Buy)
William S. Caldwell SVP - Drug Discovery and Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2010 12,000 19,735 - - Common Stock
William S. Caldwell SVP - Drug Discovery and Dev. Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Dec 2010 12,000 7,735 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 7,194 30,751 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 14,275 14,280 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 10,624 23,908 - - Stock Option (Right to Buy)
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 7,194 7,194 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 14,275 21,469 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2010 10,624 32,093 - - Common Stock
Merouane Bencherif SVP, Preclinical Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2010 32,093 0 - - Common Stock
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2010 6,354 0 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2010 4,896 0 - - Stock Option (Right to Buy)
Geoffrey C. Dunbar SVP, Clin. Dev. & Reg. Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2010 11,250 12,403 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters